Copyright Reports & Markets. All rights reserved.

Global and China Infectious Disease Rapid Diagnostic Testing Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Infectious Disease Rapid Diagnostic Testing Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 Assays
    • 1.2.3 Platforms
  • 1.3 Market by Application
    • 1.3.1 Global Infectious Disease Rapid Diagnostic Testing Market Share by Application: 2020 VS 2026
    • 1.3.2 Respiratory Infection
    • 1.3.3 Gastro-Intestinal Infection
    • 1.3.4 Center Nervous System Infection
    • 1.3.5 Hospital Acquired Infection
    • 1.3.6 Sexually Transmitted Infections
    • 1.3.7 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Infectious Disease Rapid Diagnostic Testing Market Perspective (2015-2026)
  • 2.2 Global Infectious Disease Rapid Diagnostic Testing Growth Trends by Regions
    • 2.2.1 Infectious Disease Rapid Diagnostic Testing Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Infectious Disease Rapid Diagnostic Testing Historic Market Share by Regions (2015-2020)
    • 2.2.3 Infectious Disease Rapid Diagnostic Testing Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Infectious Disease Rapid Diagnostic Testing Players by Market Size
    • 3.1.1 Global Top Infectious Disease Rapid Diagnostic Testing Players by Revenue (2015-2020)
    • 3.1.2 Global Infectious Disease Rapid Diagnostic Testing Revenue Market Share by Players (2015-2020)
  • 3.2 Global Infectious Disease Rapid Diagnostic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Infectious Disease Rapid Diagnostic Testing Revenue
  • 3.4 Global Infectious Disease Rapid Diagnostic Testing Market Concentration Ratio
    • 3.4.1 Global Infectious Disease Rapid Diagnostic Testing Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Infectious Disease Rapid Diagnostic Testing Revenue in 2019
  • 3.5 Key Players Infectious Disease Rapid Diagnostic Testing Area Served
  • 3.6 Key Players Infectious Disease Rapid Diagnostic Testing Product Solution and Service
  • 3.7 Date of Enter into Infectious Disease Rapid Diagnostic Testing Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Infectious Disease Rapid Diagnostic Testing Breakdown Data by Type (2015-2026)

  • 4.1 Global Infectious Disease Rapid Diagnostic Testing Historic Market Size by Type (2015-2020)
  • 4.2 Global Infectious Disease Rapid Diagnostic Testing Forecasted Market Size by Type (2021-2026)

5 Infectious Disease Rapid Diagnostic Testing Breakdown Data by Application (2015-2026)

  • 5.1 Global Infectious Disease Rapid Diagnostic Testing Historic Market Size by Application (2015-2020)
  • 5.2 Global Infectious Disease Rapid Diagnostic Testing Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Infectious Disease Rapid Diagnostic Testing Market Size (2015-2026)
  • 6.2 North America Infectious Disease Rapid Diagnostic Testing Market Size by Type (2015-2020)
  • 6.3 North America Infectious Disease Rapid Diagnostic Testing Market Size by Application (2015-2020)
  • 6.4 North America Infectious Disease Rapid Diagnostic Testing Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Infectious Disease Rapid Diagnostic Testing Market Size (2015-2026)
  • 7.2 Europe Infectious Disease Rapid Diagnostic Testing Market Size by Type (2015-2020)
  • 7.3 Europe Infectious Disease Rapid Diagnostic Testing Market Size by Application (2015-2020)
  • 7.4 Europe Infectious Disease Rapid Diagnostic Testing Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Infectious Disease Rapid Diagnostic Testing Market Size (2015-2026)
  • 8.2 China Infectious Disease Rapid Diagnostic Testing Market Size by Type (2015-2020)
  • 8.3 China Infectious Disease Rapid Diagnostic Testing Market Size by Application (2015-2020)
  • 8.4 China Infectious Disease Rapid Diagnostic Testing Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Infectious Disease Rapid Diagnostic Testing Market Size (2015-2026)
  • 9.2 Japan Infectious Disease Rapid Diagnostic Testing Market Size by Type (2015-2020)
  • 9.3 Japan Infectious Disease Rapid Diagnostic Testing Market Size by Application (2015-2020)
  • 9.4 Japan Infectious Disease Rapid Diagnostic Testing Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Infectious Disease Rapid Diagnostic Testing Market Size (2015-2026)
  • 10.2 Southeast Asia Infectious Disease Rapid Diagnostic Testing Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Infectious Disease Rapid Diagnostic Testing Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Infectious Disease Rapid Diagnostic Testing Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

  • 11.1 Abbott Laboratories
    • 11.1.1 Abbott Laboratories Company Details
    • 11.1.2 Abbott Laboratories Business Overview
    • 11.1.3 Abbott Laboratories Infectious Disease Rapid Diagnostic Testing Introduction
    • 11.1.4 Abbott Laboratories Revenue in Infectious Disease Rapid Diagnostic Testing Business (2015-2020))
    • 11.1.5 Abbott Laboratories Recent Development
  • 11.2 Roche Ltd
    • 11.2.1 Roche Ltd Company Details
    • 11.2.2 Roche Ltd Business Overview
    • 11.2.3 Roche Ltd Infectious Disease Rapid Diagnostic Testing Introduction
    • 11.2.4 Roche Ltd Revenue in Infectious Disease Rapid Diagnostic Testing Business (2015-2020)
    • 11.2.5 Roche Ltd Recent Development
  • 11.3 Danaher Corporation
    • 11.3.1 Danaher Corporation Company Details
    • 11.3.2 Danaher Corporation Business Overview
    • 11.3.3 Danaher Corporation Infectious Disease Rapid Diagnostic Testing Introduction
    • 11.3.4 Danaher Corporation Revenue in Infectious Disease Rapid Diagnostic Testing Business (2015-2020)
    • 11.3.5 Danaher Corporation Recent Development
  • 11.4 Luminex Corporation
    • 11.4.1 Luminex Corporation Company Details
    • 11.4.2 Luminex Corporation Business Overview
    • 11.4.3 Luminex Corporation Infectious Disease Rapid Diagnostic Testing Introduction
    • 11.4.4 Luminex Corporation Revenue in Infectious Disease Rapid Diagnostic Testing Business (2015-2020)
    • 11.4.5 Luminex Corporation Recent Development
  • 11.5 BGI Group
    • 11.5.1 BGI Group Company Details
    • 11.5.2 BGI Group Business Overview
    • 11.5.3 BGI Group Infectious Disease Rapid Diagnostic Testing Introduction
    • 11.5.4 BGI Group Revenue in Infectious Disease Rapid Diagnostic Testing Business (2015-2020)
    • 11.5.5 BGI Group Recent Development
  • 11.6 bioMerieux S.A.
    • 11.6.1 bioMerieux S.A. Company Details
    • 11.6.2 bioMerieux S.A. Business Overview
    • 11.6.3 bioMerieux S.A. Infectious Disease Rapid Diagnostic Testing Introduction
    • 11.6.4 bioMerieux S.A. Revenue in Infectious Disease Rapid Diagnostic Testing Business (2015-2020)
    • 11.6.5 bioMerieux S.A. Recent Development
  • 11.7 DiaSorin S.p.A
    • 11.7.1 DiaSorin S.p.A Company Details
    • 11.7.2 DiaSorin S.p.A Business Overview
    • 11.7.3 DiaSorin S.p.A Infectious Disease Rapid Diagnostic Testing Introduction
    • 11.7.4 DiaSorin S.p.A Revenue in Infectious Disease Rapid Diagnostic Testing Business (2015-2020)
    • 11.7.5 DiaSorin S.p.A Recent Development
  • 11.8 Hologic, Inc.
    • 11.8.1 Hologic, Inc. Company Details
    • 11.8.2 Hologic, Inc. Business Overview
    • 11.8.3 Hologic, Inc. Infectious Disease Rapid Diagnostic Testing Introduction
    • 11.8.4 Hologic, Inc. Revenue in Infectious Disease Rapid Diagnostic Testing Business (2015-2020)
    • 11.8.5 Hologic, Inc. Recent Development
  • 11.9 Mesa Biotech
    • 11.9.1 Mesa Biotech Company Details
    • 11.9.2 Mesa Biotech Business Overview
    • 11.9.3 Mesa Biotech Infectious Disease Rapid Diagnostic Testing Introduction
    • 11.9.4 Mesa Biotech Revenue in Infectious Disease Rapid Diagnostic Testing Business (2015-2020)
    • 11.9.5 Mesa Biotech Recent Development
  • 11.10 Quidel Corporation
    • 11.10.1 Quidel Corporation Company Details
    • 11.10.2 Quidel Corporation Business Overview
    • 11.10.3 Quidel Corporation Infectious Disease Rapid Diagnostic Testing Introduction
    • 11.10.4 Quidel Corporation Revenue in Infectious Disease Rapid Diagnostic Testing Business (2015-2020)
    • 11.10.5 Quidel Corporation Recent Development
  • 11.11 Thermo Fisher Scientific Inc.
    • 10.11.1 Thermo Fisher Scientific Inc. Company Details
    • 10.11.2 Thermo Fisher Scientific Inc. Business Overview
    • 10.11.3 Thermo Fisher Scientific Inc. Infectious Disease Rapid Diagnostic Testing Introduction
    • 10.11.4 Thermo Fisher Scientific Inc. Revenue in Infectious Disease Rapid Diagnostic Testing Business (2015-2020)
    • 10.11.5 Thermo Fisher Scientific Inc. Recent Development
  • 11.12 GenMark Diagnostics
    • 10.12.1 GenMark Diagnostics Company Details
    • 10.12.2 GenMark Diagnostics Business Overview
    • 10.12.3 GenMark Diagnostics Infectious Disease Rapid Diagnostic Testing Introduction
    • 10.12.4 GenMark Diagnostics Revenue in Infectious Disease Rapid Diagnostic Testing Business (2015-2020)
    • 10.12.5 GenMark Diagnostics Recent Development
  • 11.13 CTK Biotech
    • 10.13.1 CTK Biotech Company Details
    • 10.13.2 CTK Biotech Business Overview
    • 10.13.3 CTK Biotech Infectious Disease Rapid Diagnostic Testing Introduction
    • 10.13.4 CTK Biotech Revenue in Infectious Disease Rapid Diagnostic Testing Business (2015-2020)
    • 10.13.5 CTK Biotech Recent Development
  • 11.14 Becton Dickinson
    • 10.14.1 Becton Dickinson Company Details
    • 10.14.2 Becton Dickinson Business Overview
    • 10.14.3 Becton Dickinson Infectious Disease Rapid Diagnostic Testing Introduction
    • 10.14.4 Becton Dickinson Revenue in Infectious Disease Rapid Diagnostic Testing Business (2015-2020)
    • 10.14.5 Becton Dickinson Recent Development
  • 11.15 Cellex Inc.
    • 10.15.1 Cellex Inc. Company Details
    • 10.15.2 Cellex Inc. Business Overview
    • 10.15.3 Cellex Inc. Infectious Disease Rapid Diagnostic Testing Introduction
    • 10.15.4 Cellex Inc. Revenue in Infectious Disease Rapid Diagnostic Testing Business (2015-2020)
    • 10.15.5 Cellex Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Infectious Disease Rapid Diagnostic Testing Scope and Market Size
    Infectious Disease Rapid Diagnostic Testing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Infectious Disease Rapid Diagnostic Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Assays
    Platforms

    Market segment by Application, split into
    Respiratory Infection
    Gastro-Intestinal Infection
    Center Nervous System Infection
    Hospital Acquired Infection
    Sexually Transmitted Infections
    Others

    Based on regional and country-level analysis, the Infectious Disease Rapid Diagnostic Testing market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global Infectious Disease Rapid Diagnostic Testing market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Abbott Laboratories
    Roche Ltd
    Danaher Corporation
    Luminex Corporation
    BGI Group
    bioMerieux S.A.
    DiaSorin S.p.A
    Hologic, Inc.
    Mesa Biotech
    Quidel Corporation
    Thermo Fisher Scientific Inc.
    GenMark Diagnostics
    CTK Biotech
    Becton Dickinson
    Cellex Inc.

    Buy now